Alzheimer's Disease and Dementia
Our work in Alzheimer's Disease and Dementia
-
Expanding the Use of Brief Cognitive Assessments to Detect Suspected Early-Stage Cognitive Impairment in Primary Care
Providing primary care clinicians with suitable assessment tools, integrating brief cognitive assessments into routine workflows, and crafting payment policies to encourage adoption of assessments would all help improve detection.
Categorized in -
Julie Zissimopoulos to Co-Chair 2023 NIA National Research Summit on Care, Services and Support for Persons Living with Dementia
The summit provides coordinated planning efforts that respond to the national plan to address Alzheimer’s Disease.
-
2023 Alzheimer’s Trial Recruitment Innovation Lab Fellowship Program — Application Open
The University of Southern California (USC) announces an opening for a fellow to join the Alzheimer’s Trial Recruitment Innovation Lab (ATRIL) fellowship program in the fall of 2023.
-
Deep Phenotyping and Genomic Data from a Nationally Representative Study on Dementia in India
Researche present a publicly available dataset of harmonized cognitive measures of 4,096 adults 60 years of age and older in India, collected across 18 states and union territories.
Categorized in -
2023 Clinical Trial Recruitment Lab (CTRL) Request for Pilot Project Proposals – Closed
CTRL is seeking proposals for pilot projects that test strategies and solutions designed to address barriers to recruitment for Alzheimer’s disease clinical trials.
-
The Use of Telehealth Among People Living With Dementia-Caregiver Dyads During the COVID-19 Pandemic: Scoping Review. Journal of Medical Internet Research
Abstract Background: Telehealth has gained substantial attention during the COVID-19 pandemic, and reimbursement policies in health care settings have increased access to remote modes of care delivery. Telehealth has the potential to mitigate care concerns for people living with dementia and their family caregivers. There is a paucity of knowledge on the performance of telehealth […]
Categorized in -
Social and Biomedical Scientists Come Together to Address the Burden of Alzheimer’s Disease
Social scientists are uniquely poised to evaluate the implications of Alzheimer’s costs, yet they often lack knowledge of the biomedical foundations of the disease.
Categorized in -
Cost-Effectiveness Models for Alzheimer’s Disease and Related Dementias: IPECAD Modeling Workshop Cross-Comparison Challenge
Researchers established a collaboration framework to assess cost-effectiveness outcomes, an important step toward transparent and credible Alzheimer’s Disease models.
Categorized in -
CMS’s Alzheimer’s Coverage Policy Will Inhibit Access and Discourage Innovation
Individuals in underserved communities have to travel long distances, well beyond the 30-minute standard, to access clinical trial sites for Aduhelm.
Categorized in